Page last updated: 2024-08-18

isomethyleugenol and Mastocytosis, Systemic

isomethyleugenol has been researched along with Mastocytosis, Systemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albano, F; Bavaro, L; Calogero, R; Cavo, M; Ciceri, F; De Benedittis, C; Delledonne, M; Elena, C; Fontana, MC; Gangemi, D; Guadagnuolo, V; Haferlach, T; Mancini, M; Manfrini, M; Martinelli, G; Meggendorfer, M; Merante, S; Morigi, F; Padella, A; Pagano, L; Papayannidis, C; Poletti, G; Riccioni, L; Rondoni, M; Savini, P; Scaffidi, L; Soverini, S; Specchia, G; Tosi, P; Valent, P; Zago, E; Zanotti, R1
Blatt, K; Cerny-Reiterer, S; Ghanim, V; Hadzijusufovic, E; Heller, G; Herrmann, H; Karlic, H; Mirkina, I; Peter, B; Pickl, WF; Schuch, K; Valent, P; Zöchbauer-Müller, S1

Other Studies

2 other study(ies) available for isomethyleugenol and Mastocytosis, Systemic

ArticleYear
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis.
    Leukemia, 2018, Volume: 32, Issue:1

    Topics: Adult; Aged; Apoptosis; Cell Line, Tumor; Female; Histone-Lysine N-Methyltransferase; Histones; Humans; K562 Cells; Lysine; Male; Mast Cells; Mastocytosis; Mastocytosis, Systemic; Methylation; Middle Aged; Mutation; Prognosis; Proteasome Endopeptidase Complex; Staurosporine

2018
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.
    Blood, 2012, May-03, Volume: 119, Issue:18

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Base Sequence; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Drug Synergism; Fas Ligand Protein; fas Receptor; Female; Humans; Leukemia, Mast-Cell; Male; Mast Cells; Mastocytosis, Systemic; Methylation; Middle Aged; Molecular Sequence Data; Neoplasm Proteins; Point Mutation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-kit; RNA, Small Interfering

2012